We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Stone Bond Technologies EE-LIMS Earns GeneChip-compatible™ Status with the Affymetrix GeneChip® Microarray Platform

Read time: Less than a minute

Stone Bond Technologies has announced that its Enterprise Enabler® and EE-LIMS systems have achieved GeneChip-compatible™ status with the Affymetrix Inc. GeneChip® microarray platform for gene expression and genetic variation analysis in biomedical research and development.

As a GeneChip-compatible software provider and participant in the Affymetrix GeneChip-compatible Applications Program, Stone Bond’s Enterprise Enabler integrates seamlessly with the Affymetrix GeneChip microarray platform. 

As a result, laboratories can automate sample data import and test result outflow to and from the Affymetrix GeneChip Operating Software (GCOS) using Stone Bond’s EE-LIMS system, saving time, reducing errors and lowering lab administrative costs.

“Today’s lab manager is under increasing pressure to reduce administrative costs and improve efficiencies and lab economics,” noted Stone Bond President and Chief Executive Officer Antonio Szabo. 

“As genetic research becomes more complex, technology that delivers automation compatibility to leverage existing capital investments in the lab provides additive value to streamline operations and help manage research overhead costs. 

"We are honored that Affymetrix, the world leader in genetic research technology, has recognized Stone Bond’s EE-LIMS system as a compatible solution to work in partnership with their GeneChip platform.” 

“As Affymetrix customers continue to scale up and industrialize their GeneChip microarray experiments for biomedical research, LIMS systems will become more and more important,” said Steve Lincoln, vice president of Informatics at Affymetrix.

“We are pleased to be working with Stone Bond to provide critical data handling and processing in an automated manner.”

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.